Discover 276 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Dakota offers a range of options for both healthy volunteers interested in paid clinical studies and individuals with specific health conditions. Major research hubs in Sioux Falls, Rapid City, and Aberdeen are currently recruiting participants, allowing access to groundbreaking treatments and advanced medical support.
Filter
1
Filter results
Results: 276
Active & Responsive
RESPONDER-HF Trial
for
Heart Failure, Heart Failure, Diastolic
Location: 32 recruiting locations
Sponsor: Corvia Medical
Sex: All
Age: 40+
Code: NCT05425459
Recruiting
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
Location: 10 recruiting locations
Sponsor: Helix, Inc
Sex: All
Age: 18+
Code: NCT06057181
Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: 36 recruiting locations
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyftâ„¢
for
Blepharoplasty
Location: 5 recruiting locations
Sponsor: Osheru Inc.
Sex: All
Age: 35+
Code: NCT07144761
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
for
Rare Disorders, Undiagnosed Disorders,
Location: 1 recruiting location
Sponsor: Sanford Health
Sex: All
Age: 0+
Code: NCT01793168
Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: 31 recruiting locations
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase3, Recruiting
Active & Responsive
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: 47 recruiting locations
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer